Takehara, T., Sakamoto, N., Nishiguchi, S., Ikeda, F., Tatsumi, T., Ueno, Y., . . . Kurosaki, M. (2018). Efficacy and safety of sofosbuvir–velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: An open-label phase 3 trial. J Gastroenterol.
Citação norma ChicagoTakehara, Tetsuo, et al. "Efficacy and Safety of Sofosbuvir–velpatasvir With or Without Ribavirin in HCV-infected Japanese Patients With Decompensated Cirrhosis: An Open-label Phase 3 Trial." J Gastroenterol 2018.
MLA CitationTakehara, Tetsuo, et al. "Efficacy and Safety of Sofosbuvir–velpatasvir With or Without Ribavirin in HCV-infected Japanese Patients With Decompensated Cirrhosis: An Open-label Phase 3 Trial." J Gastroenterol 2018.